Alkermes
value enhancement plan includes evaluation of strategic opportunities evaluation of strategic opportunities monetization of non core assets strategic collaboration for and other oncology assets operational financial elements of legacy drug monetization of royalty delivery drug manufacturing business revenue streams from third party products platforms intellectual property preclinical and clinical assets outside of strategic portfolio risk sharing product development structures | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
32 of 144
Related slides by other companies
Ready Capital
Mergers and Acquisitions
February 2023
strategic combination between and ready capital ready capital | Ready Capital
Voyager Digital
Investor Presentation
April 2021
digital assets unlock a massive market opportunity | Voyager Digital
Snap Inc
Investor Presentation
October 2022
creator community | Snap Inc
OpenText
Investor Presentation
August 2021
strategic a foundation for our business assets on carbonite | OpenText
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io